Global Cord Blood Corp (NYSE:CO) Short Interest Down 22.5% in September

Global Cord Blood Corp (NYSE:CO) saw a significant decrease in short interest in the month of September. As of September 30th, there was short interest totalling 280,100 shares, a decrease of 22.5% from the September 15th total of 361,300 shares. Based on an average trading volume of 136,000 shares, the short-interest ratio is presently 2.1 days. Approximately 0.8% of the shares of the company are short sold.

A hedge fund recently raised its stake in Global Cord Blood stock. Marshall Wace LLP increased its stake in shares of Global Cord Blood Corp (NYSE:CO) by 8.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,012 shares of the medical research company’s stock after purchasing an additional 2,661 shares during the quarter. Marshall Wace LLP’s holdings in Global Cord Blood were worth $112,000 at the end of the most recent quarter. Institutional investors and hedge funds own 6.06% of the company’s stock.

Shares of CO traded up $0.06 during trading hours on Friday, reaching $3.54. 44,314 shares of the company traded hands, compared to its average volume of 145,908. The stock’s fifty day moving average is $3.46 and its 200 day moving average is $3.20. The stock has a market cap of $430.29 million, a P/E ratio of 6.21 and a beta of 0.51. Global Cord Blood has a 1-year low of $2.54 and a 1-year high of $5.79.

Global Cord Blood (NYSE:CO) last announced its quarterly earnings data on Monday, August 24th. The medical research company reported $0.15 EPS for the quarter. The business had revenue of $39.76 million during the quarter. Global Cord Blood had a net margin of 40.29% and a return on equity of 12.88%.

Global Cord Blood Company Profile

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services.

Read More: Net Margin – Understanding the Different Kinds of Profit

Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.